Overview
Quote
Description
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Japan
Chart
Financials
Key metrics
| Market capitalisation, EUR | 39,145 m |
| EPS, EUR | 0.13 |
| P/B ratio | 1.0 |
| P/E ratio | 206.3 |
| Dividend yield | 4.45% |
Income statement (2024)
| Revenue, EUR | 28,029 m |
| Net income, EUR | 660 m |
| Profit margin | 2.36% |
What ETF is Takeda Pharmaceutical Co., Ltd. in?
There are 58 ETFs which contain Takeda Pharmaceutical Co., Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Takeda Pharmaceutical Co., Ltd. is the iShares MSCI Japan ESG Enhanced CTB UCITS ETF USD (Dist).
Performance
Returns overview
| YTD | -2.89% |
| 1 month | +3.76% |
| 3 months | -6.19% |
| 6 months | -6.11% |
| 1 year | -5.46% |
| 3 years | -12.25% |
| 5 years | -20.74% |
| Since inception (MAX) | -40.28% |
| 2024 | -2.47% |
| 2023 | -10.49% |
| 2022 | +19.01% |
| 2021 | -18.32% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 17.96% |
| Volatility 3 years | 17.56% |
| Volatility 5 years | 18.55% |
| Return per risk 1 year | -0.30 |
| Return per risk 3 years | -0.24 |
| Return per risk 5 years | -0.24 |
| Maximum drawdown 1 year | -18.06% |
| Maximum drawdown 3 years | -26.10% |
| Maximum drawdown 5 years | -30.32% |
| Maximum drawdown since inception | -54.22% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
